Search Results - "De La Mora, Lorena"
-
1
Tolerability of bictegravir/tenofovir alafenamide/emtricitabine versus dolutegravir/lamivudine as maintenance therapy in a real-life setting
Published in Journal of antimicrobial chemotherapy (01-12-2023)“…While both the burden of therapy and the individual drugs in bictegravir/tenofovir alafenamide/emtricitabine (BIC/TAF/FTC) and dolutegravir/lamivudine differ,…”
Get full text
Journal Article -
2
Efficacy and safety of raltegravir plus lamivudine maintenance therapy
Published in Journal of antimicrobial chemotherapy (01-02-2024)“…Decreasing medication burden with raltegravir plus lamivudine in virologically suppressed persons with HIV (PWH) maintained efficacy and was well tolerated at…”
Get full text
Journal Article -
3
Long-term evolution in liver fibrosis and immune profile after direct-acting antivirals therapy in hepatitis C virus-human immunodeficiency virus co-infected patients
Published in Clinical microbiology and infection (01-04-2022)“…Hepatitis C virus (HCV) therapy with direct-acting antivirals (DAA) achieves high rates of sustained virological response in people living with human…”
Get full text
Journal Article -
4
Prevalence, risk factors and the impact of tenofovir treatment in SARS-CoV-2 infection and COVID-19 disease among people living with HIV: A cross-sectional population-based study
Published in International journal of infectious diseases (01-12-2024)“…•High prevalence of SARS-CoV-2 infection in unvaccinated people with HIV (PWH).•67.5% of SARS-CoV-2 cases in PWH were asymptomatic.•Risk factors: young age,…”
Get full text
Journal Article -
5
Impact of low serum calcium at hospital admission on SARS-CoV-2 infection outcome
Published in International journal of infectious diseases (01-03-2021)“…•Almost two thirds of patients with SARS-CoV-2 infection present with hypocalcemia at hospital admission.•Hypocalcemia at admission is related to high oxygen…”
Get full text
Journal Article -
6
Effect of Intranodally Administered Dendritic Cell-Based HIV Vaccine in Combination With Pegylated Interferon α-2a on Viral Control Following ART Discontinuation: A Phase 2A Randomized Clinical Trial
Published in Frontiers in immunology (11-11-2021)“…Functional cure has been proposed as an alternative to lifelong antiretroviral therapy and therapeutic vaccines represent one of the most promising approaches…”
Get full text
Journal Article -
7
Toxic-Induced Encephalopathy Following Chemsex in a Young HIV-Positive Male: A Complex Case of Acute Cognitive Impairment with Anterograde Amnesia and Behavioral Alterations
Published in Infectious diseases and therapy (01-04-2024)“…background A broadened clinical spectrum of concomitant complications emerges among the escalating incidence of substance use, particularly within the…”
Get full text
Journal Article -
8
Gustatory and olfactory dysfunctions in hospitalised patients with COVID-19 pneumonia: a prospective study
Published in BMJ open (17-08-2021)“…ImportanceIdentifying undetected clinical signs is imperative in the prevention of SARS-CoV-2.ObjectiveTo establish the prevalence of clinical gustatory and…”
Get full text
Journal Article -
9
Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years’ Experience
Published in Infectious diseases and therapy (01-02-2023)“…Introduction Pre-exposure prophylaxis (PrEP) is effective for HIV prevention, but the PrEP care continuum also involves improving PrEP awareness, uptake,…”
Get full text
Journal Article -
10
Increasing of New CA-MRSA Infections Detected in people living with HIV Who Engage in Chemsex in Barcelona: An Ambispective Study
Published in Infectious diseases and therapy (01-08-2023)“…Introduction There are no data on community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections in the context of the chemsex…”
Get full text
Journal Article -
11
Uso de metanfetamina en el contexto chemsex y sus consecuencias en la salud mental: Un estudio descriptivo
Published in Revista española de salud pública (2021)“…Background: Chemsex is a term applicable to the use of drugs related to sex among men who have sex with men (MSM). Because it is a recent trend, there is…”
Get full text
Journal Article -
12
Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study
Published in Clinical microbiology and infection (01-01-2021)“…To describe the burden, epidemiology and outcomes of co-infections and superinfections occurring in hospitalized patients with coronavirus disease 2019…”
Get full text
Journal Article -
13
Clinical characteristics, risk factors, and incidence of symptomatic coronavirus disease 2019 in a large cohort of adults living with HIV: a single-center, prospective observational study
Published in AIDS (London) (01-10-2020)“…BACKGROUND:It is unclear how characteristics, risk factors, and incidence of coronavirus disease 2019 (COVID-19) in people living with HIV (PLWH) differ from…”
Get full text
Journal Article -
14
Epidemiology, treatment and prognosis of HIV infection in 2024: A practical review
Published in Medicina clínica (English ed.) (14-06-2024)“…In recent years, the epidemiology and prognosis of HIV infection have undergone significant changes thanks to the recommendation of antiretroviral therapy…”
Get full text
Journal Article -
15
Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre
Published in Journal of antimicrobial chemotherapy (31-03-2022)“…Abstract Background The use of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) is mainly based on robust, pivotal clinical trials. Objectives To…”
Get full text
Journal Article -
16
Integrase resistance emergence with dolutegravir/lamivudine with prior HIV-1 suppression
Published in Journal of antimicrobial chemotherapy (29-05-2022)“…Integrase resistance has not been reported with co-formulated dolutegravir/lamivudine in clinical trials or real-life cohorts. We aim to report, to the best of…”
Get full text
Journal Article -
17
An unexpected adverse effect: Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide-induced cholestasis
Published in Antiviral therapy (01-01-2021)Get more information
Journal Article -
18
Personalized Therapy Approach for Hospitalized Patients with Coronavirus Disease 2019
Published in Clinical infectious diseases (07-01-2022)“…Abstract Hospitalized patients with coronavirus disease 2019 (COVID-19) experiencing respiratory symptoms have different complications (inflammatory,…”
Get full text
Journal Article -
19
Overview of SARS-CoV-2 infection in adults living with HIV
Published in The lancet HIV (01-05-2021)“…Around 2·5 million deaths and more than 110 million COVID-19 cases have been reported globally. Although it initially appeared that HIV infection was not a…”
Get full text
Journal Article -
20
Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study
Published in Journal of antimicrobial chemotherapy (03-09-2024)“…Abstract Introduction Rapid initiation of ART after HIV diagnosis is recommended for individual and public health benefits. However, certain clinical and…”
Get full text
Journal Article